SJB2-043, a USP1 Inhibitor, Suppresses A549 Cell Proliferation, Migration, and EMT via Modulation of PI3K/AKT/mTOR, MAPK, and Wnt Signaling Pathways
Li Wu(State Key Laboratory of Respiratory Disease), Chuwen Li(State Key Laboratory of Respiratory Disease), Yuanye Dang(State Key Laboratory of Respiratory Disease), Halimulati Muhetaer(State Key Laboratory of Respiratory Disease), Huajian Li(State Key Laboratory of Respiratory Disease), Guangyang Chen(State Key Laboratory of Respiratory Disease), Jingjing Li(Shanghai University), Meng Yu(Wenzhou-Kean University), Long Lin(University of Copenhagen), Bo Wu(State Key Laboratory of Respiratory Disease), Hongge Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Guodong Zheng(State Key Laboratory of Respiratory Disease), Xuejing Jia(Guangdong Ocean University)
Cited by 6
Related Papers
<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis</p>
|OncoTargets and Therapy|2020|111
Inhibitory Effects of Betulinic Acid on LPS-Induced Neuroinflammation Involve M2 Microglial Polarization via CaMKKβ-Dependent AMPK Activation
|Frontiers in Molecular Neuroscience|2018|67
PI3K in Cancer: Its Structure, Activation Modes and Role in Shaping Tumor Microenvironment
|Future Oncology|2017|65
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
|OncoTargets and Therapy|2018|55
<p>Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer</p>
|Cancer Management and Research|2019|51